sndx-5613
Showing 1 - 5 of 5
Relapsed/Refractory Acute Leukemia Trial (SNDX-5613)
Available
- Relapsed/Refractory Acute Leukemia
- SNDX-5613
- (no location specified)
Jun 15, 2023
Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- Solid Tumors
- SNDX-5613
- Chemotherapy
- (no location specified)
Feb 15, 2023
Acute Myeloid Leukemia Trial in Houston (SNDX-5613)
Recruiting
- Acute Leukemia
- SNDX-5613
-
Houston, TexasMD Anderson Cancer Center
Oct 3, 2022
Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)
Recruiting
- Acute Myeloid Leukemia
- SNDX-5613
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2022
Relapsed/Refractory Leukemias, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Trial in Kansas City, Cincinnati
Recruiting
- Relapsed/Refractory Leukemias
- +4 more
- SNDX-5613
- +2 more
-
Kansas City, Missouri
- +1 more
Jul 18, 2022